For me this is a very interesting topic that just has not been studied to any extent.
Oh don't get me wrong bc I don't believe it's the smoking gun of adverse effects from AAS use.
We ALL know the overwhelming majority of those who have used AAS are GTG to this day, so something else is required and that list is endless from genetics, to a specific AAS, some combination or their dosage and duration of use.
I'm not trying to open up a Pandora's box with my suggestions, but how many of you mates have heard some AAS brethren mention a reduced aerobic capacity while cycling Tren!
So I reflect back and wonder how many of my patients with "idiopathic cardiomyopathy" would have had Echocargraphic abnormalities of cardiac dysfunction?
I honestly don't know but if I can document an temporal relationship using a few select case studies, perhaps this issue would receive the attention and research it deserves.
Oh don't get me wrong bc I don't believe it's the smoking gun of adverse effects from AAS use.
We ALL know the overwhelming majority of those who have used AAS are GTG to this day, so something else is required and that list is endless from genetics, to a specific AAS, some combination or their dosage and duration of use.
I'm not trying to open up a Pandora's box with my suggestions, but how many of you mates have heard some AAS brethren mention a reduced aerobic capacity while cycling Tren!
So I reflect back and wonder how many of my patients with "idiopathic cardiomyopathy" would have had Echocargraphic abnormalities of cardiac dysfunction?
I honestly don't know but if I can document an temporal relationship using a few select case studies, perhaps this issue would receive the attention and research it deserves.
Last edited: